WANBANGDE PHARMACEUTICAL HOLDING GROUP CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.44 CNY | -1.33% |
|
-0.45% | -30.62% |
| 05-20 | Wanbangde Pharmaceutical Holding Group Co., Ltd. Approves Dividend for the Year 2023 | CI |
| 05-08 | US FDA Gives Rare Pediatric Disease Drug Designation to Wanbangde Pharmaceutical's Huperzine A | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 374M | - | - | - | - | - | |
| 43.54B | ||||||
| 21.78B | ||||||
| 15.38B | ||||||
| 15.12B | ||||||
| 13.36B |
